albumim

About

Human albumin treatment in adult septic shock. A phase 2, multicenter, randomized, placebo-controlled study evaluating the immune response and organ failure.

Description

  • To assess if albumin treatment increases B cell gene expression, as estimated by the immunoglobulin complex gene set (ICGS) score, in non-cirrhotic patients with septic shock
  • To investigate potential mechanisms of this effect

Non-cirrhotic patients hospitalized with sepsis

Centers

Barcelona, Spain

  • Hospital Clínic de Barcelona
  • Hospital de la Santa Creu i Sant Pau
  • Hospital Universitari Vall d’Hebron

Madrid, Spain

  • Hospital Universitario de Getafe

Sabadell, Spain

  • Hospital Universitari Parc Taulí de Sabadell

 

Cookies | Privacy | Terms & conditions


© 2022 Albimmune

 

Registered office:
Travessera
 de Gràcia 11, 7th floor

08021 Barcelona | Spain

T +34 932 271 400

E info@albimmune.com

albimmune.com